Cell & Gene: The Podcast

4 Keys to Allo in 2024 with Poseida Therapeutics' Kristin Yarema, Ph.D.

Erin Harris Episode 66

Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.

0:00 | 31:59

We love to hear from our listeners. Send us a message.

Kristin Yarema, Ph.D., CEO, Poseida Therapeutics sits down with Cell & Gene: The Podcast Host Erin Harris to discuss four of the biggest challenges the CGT sector faces when it comes to the development of off-the-shelf therapies. Kristin shares how 2024 might see some real progress in allogeneic therapies. 

Subscribe to the podcast!
Apple  |  SpotifyYouTube

Visit my website: Cell & Gene

Connect with me on LinkedIn

Podcasts we love

Check out these other fine podcasts recommended by us, not an algorithm.